Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121669) titled 'Precision Intervention Strategies to Balance Antitumor Efficacy and Immune Toxicity Control in Immune Checkpoint Inhibitor-Related Colitis' on April 1.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Condition:
Immune checkpoint inhibitor-related colitis
Intervention:
irAE-controlled & efficacy-maintained group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-01
Target Sample Size: irAE-controlled & efficacy-maintained group:16;irAE-controlled & efficacy-reduced...